Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1993 Aug;218(2):152–158. doi: 10.1097/00000658-199308000-00006

Increased bile duct complications in liver transplantation across the ABO barrier.

L Sanchez-Urdazpal 1, K P Batts 1, G J Gores 1, S B Moore 1, S Sterioff 1, R H Wiesner 1, R A Krom 1
PMCID: PMC1242924  PMID: 8342994

Abstract

OBJECTIVE: This study evaluated the outcome of liver grafts from ABO incompatible donors, focusing on biliary complications, and compared the results to an ABO compatible control group. Also, the expression of donor ABH antigens in the liver graft was analyzed. SUMMARY BACKGROUND DATA: The outcome of liver transplantation using an ABO incompatible graft is still debated. These blood group related (ABH) antigens are known to be expressed not only on the surface of the erythrocytes, but also on the epithelial cells of large bile ducts. Because the biliary epithelium of hepatic allografts may continue to express donor ABH antigens, it may be more susceptible to immunologic bile duct injury after transplantation across the ABO barrier. METHODS: Eighteen ABO incompatible grafts were compared with 18 ABO compatible grafts in patients who were matched according to medical urgency, primary liver disease (PLD), and recipient age. After transplantation, the grafts were analyzed with cholangiography, Doppler ultrasound, or arteriography and liver histology according to protocol. Immunoperoxidase staining for ABH antigens was performed on hepatic tissue. RESULTS: Biliary complications developed in 82% of the ABO incompatible donors, compared to 6% of the ABO matched controls. Hepatic artery thrombosis occurred in 24%. Cellular rejection was diagnosed in 65% versus only 28% in the control group. The 1-year actuarial graft survival rate was 44% versus 78% in the control group. ABH antigens of the donor were expressed on vascular endothelium and bile duct epithelial cells as long as 150 days after transplant. CONCLUSIONS: Using ABO incompatible allografts, a high incidence of biliary and hepatic artery complications and decreased graft survival in liver transplantation were found. An immunologic injury to the bile duct epithelium and/or to vascular endothelium is suspected.

Full text

PDF
152

Images in this article

155Figure 1.
on p.155
157Figure 2.
on p.157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexandre G. P., Squifflet J. P., De Bruyère M., Latinne D., Reding R., Gianello P., Carlier M., Pirson Y. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc. 1987 Dec;19(6):4538–4542. [PubMed] [Google Scholar]
  2. Belle S. H., Detre K. M., Beringer K. C., Murphy J. B., Vaughn W. K. Liver transplantation in the United States: 1988 to 1989. Clin Transpl. 1990:11–19. [PubMed] [Google Scholar]
  3. Demetris A. J., Jaffe R., Tzakis A., Ramsey G., Todo S., Belle S., Esquivel C., Shapiro R., Markus B., Mroczek E. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol. 1988 Sep;132(3):489–502. [PMC free article] [PubMed] [Google Scholar]
  4. Demetris A. J., Jaffe R., Tzakis A., Ramsey G., Todo S., Belle S., Esquivel C., Shapiro R., Zjako A., Markus B. Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers. Transplant Proc. 1989 Feb;21(1 Pt 2):2217–2220. [PMC free article] [PubMed] [Google Scholar]
  5. Ernst C., Thurin J., Atkinson B., Wurzel H., Herlyn M., Stromberg N., Civin C., Koprowski H. Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues. Am J Pathol. 1984 Dec;117(3):451–461. [PMC free article] [PubMed] [Google Scholar]
  6. Fischel R. J., Ascher N. L., Payne W. D., Freese D. K., Stock P., Fasola C., Najarian J. S. Pediatric liver transplantation across ABO blood group barriers. Transplant Proc. 1989 Feb;21(1 Pt 2):2221–2222. [PubMed] [Google Scholar]
  7. Fuller T. C., Phelan D., Gebel H. M., Rodey G. E. Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test. Transplantation. 1982 Jul;34(1):24–29. doi: 10.1097/00007890-198207000-00005. [DOI] [PubMed] [Google Scholar]
  8. Gordon R. D., Iwatsuki S., Esquivel C. O., Tzakis A., Todo S., Starzl T. E. Liver transplantation across ABO blood groups. Surgery. 1986 Aug;100(2):342–348. [PubMed] [Google Scholar]
  9. Gugenheim J., Samuel D., Reynes M., Bismuth H. Liver transplantation across ABO blood group barriers. Lancet. 1990 Sep 1;336(8714):519–523. doi: 10.1016/0140-6736(90)92082-s. [DOI] [PubMed] [Google Scholar]
  10. Krom R. A., Wiesner R. H., Rettke S. R., Ludwig J., Southorn P. A., Hermans P. E., Taswell H. F. The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc. 1989 Jan;64(1):84–94. doi: 10.1016/s0025-6196(12)65307-5. [DOI] [PubMed] [Google Scholar]
  11. Ludwig J. Classification and terminology of hepatic allograft rejection: whither bound? Mayo Clin Proc. 1989 Jun;64(6):676–679. doi: 10.1016/s0025-6196(12)65347-6. [DOI] [PubMed] [Google Scholar]
  12. Ludwig J., Wiesner R. H., Batts K. P., Perkins J. D., Krom R. A. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Hepatology. 1987 May-Jun;7(3):476–483. doi: 10.1002/hep.1840070311. [DOI] [PubMed] [Google Scholar]
  13. Nakanuma Y., Sasaki M. Expression of blood group-related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases. Hepatology. 1989 Aug;10(2):174–178. doi: 10.1002/hep.1840100209. [DOI] [PubMed] [Google Scholar]
  14. Okada Y., Jinno K., Moriwaki S., Shimoe T., Tsuji T., Murakami M., Thurin J., Koprowski H. Blood group antigens in the intrahepatic biliary tree. I. Distribution in the normal liver. J Hepatol. 1988 Feb;6(1):63–70. doi: 10.1016/s0168-8278(88)80463-x. [DOI] [PubMed] [Google Scholar]
  15. Rapaport F. T., Dausset J. Activity of the ABO antigen system as a determinant of histocompatibility in human transplantation. Transplant Proc. 1987 Dec;19(6):4487–4491. [PubMed] [Google Scholar]
  16. Rydberg L., Breimer M. E., Brynger H., Samuelsson B. E. ABO-incompatible kidney transplantation (A2 to O). Qualitative and semiquantitative studies of the humoral immune response against different blood group A antigens. Transplantation. 1990 May;49(5):954–960. [PubMed] [Google Scholar]
  17. STARZL T. E., MARCHIORO T. L., HOLMES J. H., HERMANN G., BRITTAIN R. S., STONINGTON O. H., TALMAGE D. W., WADDELL W. R. RENAL HOMOGRAFTS IN PATIENTS WITH MAJOR DONOR-RECIPIENT BLOOD GROUP INCOMPATIBILITIES. Surgery. 1964 Feb;55:195–200. [PMC free article] [PubMed] [Google Scholar]
  18. Starzl T. E., Iwatsuki S., Van Thiel D. H., Gartner J. C., Zitelli B. J., Malatack J. J., Schade R. R., Shaw B. W., Jr, Hakala T. R., Rosenthal J. T. Evolution of liver transplantation. Hepatology. 1982 Sep-Oct;2(5):614–636. doi: 10.1002/hep.1840020516. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES